Which has grown faster, ABCL or LIVN?

Over the past five years, LIVN grew revenue faster — ABCL at a -31.78% CAGR versus LIVN at 7.57%.

Is ABCL or LIVN more profitable?

LIVN runs the higher net margin — ABCL at -248.83% versus LIVN at 12.82%.

How have ABCL and LIVN total returns compared?

Over the past 5 years, ABCL delivered -3.57% and LIVN delivered -1.66% annualized total return. Past performance doesn't predict future results.

AbCellera Biologics Inc. (ABCL) vs LivaNova PLC (LIVN)

A side-by-side comparison of AbCellera Biologics Inc. and LivaNova PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABCL

AbCellera Biologics Inc.

$4.03B

$13.18HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

LIVN

LivaNova PLC

$4.13B

$75.24HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT

Total return — ABCL vs LIVN

growth of $100 · dividends reinvested · last 6y

ABCL -76.6% (-21.5%/yr)LIVN +23.0% (+3.5%/yr)LIVN compounded faster over this window

Log scale — wide-divergence pair

ABCL LIVN

ABCL vs LIVN: by the numbers

•LIVN is the larger company ($4.13B vs $4.03B market cap).
•LIVN is profitable (12.82% net margin) while ABCL runs a net loss (-248.83%).
•LIVN grew revenue faster over the past five years (7.57% vs -31.78% CAGR).

Metrics side by side

Valuation

Metric	ABCL	LIVN
P/E ratio	N/A	22.19
Forward P/E	N/A	17.27
P/S ratio	60.83	2.81
P/B ratio	4.49	3.12
EV / EBITDA	N/A	16.24
FCF yield	N/A	3.59%

Profitability

Metric	ABCL	LIVN
Gross margin	61.64%	68.18%
Operating margin	-288.98%	13.48%
Net margin	-248.83%	12.82%
ROE	-18.38%	14.23%
ROIC	-17.95%	10.24%

Growth (annualized)

Metric	ABCL	LIVN
Revenue CAGR (5Y)	-31.78%	7.57%
FCF CAGR (5Y)	N/A	20.23%
Total return CAGR (5Y)	-3.57%	-1.66%

Frequently asked

Which has grown faster, ABCL or LIVN?: Over the past five years, LIVN grew revenue faster — ABCL at a -31.78% CAGR versus LIVN at 7.57%.
Is ABCL or LIVN more profitable?: LIVN runs the higher net margin — ABCL at -248.83% versus LIVN at 12.82%.
How have ABCL and LIVN total returns compared?: Over the past 5 years, ABCL delivered -3.57% and LIVN delivered -1.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABCL analysis Full LIVN analysis Interactive comparison tool

Dig into the metrics

LivaNova P/E ratio AbCellera Biologics ROE LivaNova ROE AbCellera Biologics operating margin LivaNova operating margin AbCellera Biologics revenue growth LivaNova revenue growth AbCellera Biologics free cash flow LivaNova free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.